Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-blind Phase 2 trial of BF 2.649 in adults with ADHD
2005-005012-25Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of pitolisant in attention deficit hyperactivity disorder (ADHD), sponsored by Bioprojet. Primary endpoint: Clinical response at 4 weeks. Started Nov 2005; status: completed.
02
Drugs
pitolisant
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2005-005012-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005012-25.